课题基金 / 基金详情

DEPRESSION, 5-HT1A RECEPTOR & NEUROPLASTICITY

DEPRESSION, 5-HT1A RECEPTOR & NEUROPLASTICITY
抑郁症,5-HT1A 受体
批准号:
6828325
负责人:
Efrain C Azmitia
金额:
$21.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2006-11-30

项目摘要

项目成果

Efrain C Azmitia的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from applicant's abstract) Depression is associated with affective and cognitive disorders. The applicant suggest some of these symptoms may be due to loss of hippocampal and cortical morphology (cytoskeletal collapse) induced by loss of serotonin. Loss of serotonin in the adult rat brain produces decreased dendritic length, dendritic spine number and size, synapse number and a reduction in immunoreactivity to antibodies against neuronal (Microtubule Associated Protein-2 and synaptophysin) and glial (S-lOOn) markers. Injection with a 5-HT1A antagonist produces similar loss of synapses and dendritic spines. The loss of neuronal and glial markers is reversed by treatment with 5-HTIA receptor agonists and S-100beta. This renewal application will test the hypothesis that the 5-HT1A receptor stabilize the neuronal cytoskeletal by targeting neurons and glial cells, and may protect neurons from death (apoptosis). The applicant would like to continue and expand our studies on the effects of 5-HT drugs on morphological reversal after 5-HT loss proposed in the onginal grant. In addition, the applicants now propose the 5-HT1A receptor may regulate the cytoskeleton of neurons, by acting both on glial (availability of S100f3) and neurons (receptor-induced changes in phosphorylation pathways (e.g. PKC, PKA and MAPK)). In addition, The applicant would like to test if 5-HT1A receptor stimulation or S lOObeta treatmnent will restore the cytoskeleton after exposure to coichicine. Coichicine promotes microtubule disassembly and promotes apoptosis in culture and in vivo. Rats will be injected with para-chloroamphetamine (PCA) to reduce 5-HT levels The applicant will treat these rats with either a 5-HT1A receptor antagonist, tricyclics, serotonin specific reuptake inhibitors (SSRJ) or MAO-A inhibitor. In addition, the applicants will study possible mechanisms of action after exposure of cultured neurons to 5-HT1A receptor agonist and S-lOObeta. The applicants hope to extend this work to primary hippocampal and cortical neuronal and glial cultures using wild type and knockout (S100beta and the 5-HT1A receptor) mice. Finally, the actions of S-HT1A agonist and S-lOObeta will be studied after microinjections of colchicine into the adult rat hippocampus and cortex. The applicant will focus on dendritic collapse and apoptosis of neurons. This work will continue our long-term research into the interactions between serotonin and adult neumplasticity.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
S100beta protein expression: gender- and age-related daily changes.
S100beta 蛋白表达:性别和年龄相关的日常变化。
DOI: 10.1007/s11064-009-9915-x
发表时间: 2009
期刊: Neurochemical research
影响因子: 4.4
作者: [Nogueira,MI, Abbas,SY, Campos,LGM, Allemandi,W, Lawson,P, Takada,SH, Azmitia,EC]
通讯作者: Azmitia,EC
Serotonin neurons, neuroplasticity, and homeostasis of neural tissue.
血清素神经元、神经可塑性和神经组织的稳态。
DOI: 10.1016/s0893-133x(99)00022-6
发表时间: 1999
期刊: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子: --
作者: [Azmitia,EC]
通讯作者: Azmitia,EC
5-HT1A receptor agonist reverses adrenalectomy-induced loss of granule neuronal morphology in the rat dentate gyrus.
5-HT1A 受体激动剂可逆转肾上腺切除术引起的大鼠齿状回颗粒神经元形态的丧失。
DOI: 10.1023/a:1022062921438
发表时间: 1997
期刊: Neurochemical research
影响因子: 4.4
作者: [Huang,J, Strafaci,JA, Azmitia,EC]
通讯作者: Azmitia,EC
Serotoninergic chemoreceptive neurons: a search for a shared function.
血清素能化学感受神经元:寻找共享功能。
DOI: 10.1124/mi.4.1.18
发表时间: 2004
期刊: Molecular interventions
影响因子: --
作者: [Azmitia,EfrainC]
通讯作者: Azmitia,EfrainC
7
    MENTAL HEALTH 5 HTIA RECEPTOR AND NEUROPLASTICITY
    • 批准号:
      6742493
    • 项目类别:
    • 资助金额:
      $12.1万
    • 财政年份:
      2001
    • 负责人:
      Efrain C Azmitia
    • 依托单位:
    MENTAL HEALTH 5 HTIA RECEPTOR AND NEUROPLASTICITY
    • 批准号:
      6538289
    • 项目类别:
    • 资助金额:
      $12.1万
    • 财政年份:
      2001
    • 负责人:
      Efrain C Azmitia
    • 依托单位:
    MENTAL HEALTH 5 HTIA RECEPTOR AND NEUROPLASTICITY
    • 批准号:
      6638892
    • 项目类别:
    • 资助金额:
      $12.1万
    • 财政年份:
      2001
    • 负责人:
      Efrain C Azmitia
    • 依托单位:
    MENTAL HEALTH 5 HTIA RECEPTOR AND NEUROPLASTICITY
    • 批准号:
      6888128
    • 项目类别:
    • 资助金额:
      $12.1万
    • 财政年份:
      2001
    • 负责人:
      Efrain C Azmitia
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: